Literature DB >> 29600327

The histamine H4 receptor modulates the differentiation process of human monocyte-derived M1 macrophages and the release of CCL4/MIP-1β from fully differentiated M1 macrophages.

Susanne Mommert1, Lisanne Ratz2, Holger Stark3, Ralf Gutzmer2, Thomas Werfel2.   

Abstract

OBJECTIVE: Histamine is an important mediator of biological functions and present in high amounts in inflammatory skin lesions which are characterised by a marked infiltration of myeloid derived cell populations. The aim of the study was to investigate the expression and function of histamine receptors, with a focus on the histamine H4 receptor (H4R) in detail during the differentiation process from monocytes to macrophages and on fully differentiated M1 macrophages.
METHODS: Quantitative PCR, ELISA technique, and flow cytometry were applied to analyze expression levels of histamine receptors, of CXCL10, CCL4, CCL3, or IL-23 and of the macrophage differentiation marker CD68, respectively.
RESULTS: We demonstrated that monocytes and fully differentiated M1 macrophages express H1R-, H2R-, and H4R mRNA which were differentially regulated during the differentiation process and in IFN-Ƴ and LPS classically activated M1 macrophages. The H3R mRNA was not expressed. During in vitro differentiation from monocytes to macrophages, the H4R agonist ST-1006 modified the M1 phenotype by up-regulating the macrophage differentiation marker CD68, by down-regulating the production of CXCL10, and by changing the morphology. In fully differentiated M1 macrophages, histamine or ST-1006 decreased the IFN-Ƴ- and LPS-induced CCL4 mRNA expression and protein production, whereas CCL3 or IL-23 production was not regulated via H4R.
CONCLUSIONS: We describe novel immunomodulatory functions of the H4R during the differentiation process of human monocyte-derived macrophages and in fully differentiated M1 macrophages. The down-regulation of Th1-related chemokines during the differentiation process or in classically activated macrophages via H4R may contribute to decreased migration of immune cells to the site of inflammation. This may have implications for the treatment of allergic diseases with H4R ligands regulating the dysbalance of Th2/Th1 polarizations in these disorders.

Entities:  

Keywords:  Cell shape; Histamine H4 receptor; M1 macrophages

Mesh:

Substances:

Year:  2018        PMID: 29600327     DOI: 10.1007/s00011-018-1140-0

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  37 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

2.  Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites.

Authors:  Robert M Anthony; Joseph F Urban; Farhang Alem; Hossein A Hamed; Cristina T Rozo; Jean-Luc Boucher; Nico Van Rooijen; William C Gause
Journal:  Nat Med       Date:  2006-07-30       Impact factor: 53.440

3.  Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis.

Authors:  Eva Gros; Caroline Bussmann; Thomas Bieber; Irmgard Förster; Natalija Novak
Journal:  J Allergy Clin Immunol       Date:  2009-09-19       Impact factor: 10.793

4.  The histamine H4 receptor regulates chemokine production in human natural killer cells.

Authors:  Susanne Mommert; Oliver Dittrich-Breiholz; Holger Stark; Ralf Gutzmer; Thomas Werfel
Journal:  Int Arch Allergy Immunol       Date:  2015-04-24       Impact factor: 2.749

5.  Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells.

Authors:  Ralf Gutzmer; Carola Diestel; Susanne Mommert; Brigitta Köther; Holger Stark; Miriam Wittmann; Thomas Werfel
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

6.  CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.

Authors:  Necil Kutukculer; Elif Azarsiz; Guzide Aksu; Neslihan Edeer Karaca
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

7.  Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins.

Authors:  C L Holness; D L Simmons
Journal:  Blood       Date:  1993-03-15       Impact factor: 22.113

8.  The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects.

Authors:  Alexa Kollmeier; Klaus Francke; Bin Chen; Paul J Dunford; Andrew J Greenspan; Yichuan Xia; Xie L Xu; Bei Zhou; Robin L Thurmond
Journal:  J Pharmacol Exp Ther       Date:  2014-05-09       Impact factor: 4.030

9.  Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome.

Authors:  T Ruzicka; S Glück
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

10.  Histamine downregulates the Th1-associated chemokine IP-10 in monocytes and myeloid dendritic cells.

Authors:  Franziska Glatzer; Susanne Mommert; Brigitta Köther; Maria Gschwandtner; Holger Stark; Thomas Werfel; Ralf Gutzmer
Journal:  Int Arch Allergy Immunol       Date:  2013-11-16       Impact factor: 2.749

View more
  11 in total

1.  Stimulation of histamine H4 receptors increases the production of IL-9 in Th9 polarized cells.

Authors:  Katrin Schaper-Gerhardt; Mareike Wohlert; Susanne Mommert; Manfred Kietzmann; Thomas Werfel; Ralf Gutzmer
Journal:  Br J Pharmacol       Date:  2019-02-21       Impact factor: 8.739

Review 2.  The role of the histamine H4 receptor in atopic dermatitis and psoriasis.

Authors:  Katrin Schaper-Gerhardt; Kristine Rossbach; Eirini Nikolouli; Thomas Werfel; Ralf Gutzmer; Susanne Mommert
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

3.  Histidine decarboxylase deficiency inhibits NBP-induced extramedullary hematopoiesis by modifying bone marrow and spleen microenvironments.

Authors:  Hirotada Otsuka; Yasuo Endo; Hiroshi Ohtsu; Satoshi Inoue; Syunya Noguchi; Masanori Nakamura; Satoshi Soeta
Journal:  Int J Hematol       Date:  2021-01-04       Impact factor: 2.490

Review 4.  Histamine in the Crosstalk Between Innate Immune Cells and Neurons: Relevance for Brain Homeostasis and Disease.

Authors:  Liliana Bernardino
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  Identification of Differentially Expressed lncRNAs and mRNAs in Children with Acquired Aplastic Anemia by RNA Sequencing.

Authors:  Shuanglong Lu; Xiaoxiao Song; Jing Chen; Xiaohong Qiao
Journal:  Biomed Res Int       Date:  2020-06-28       Impact factor: 3.411

6.  Histamine up-regulates oncostatin M expression in human M1 macrophages.

Authors:  Susanne Mommert; Marius Hüer; Katrin Schaper-Gerhardt; Ralf Gutzmer; Thomas Werfel
Journal:  Br J Pharmacol       Date:  2019-12-11       Impact factor: 8.739

7.  Histamine Increases Th2 Cytokine-Induced CCL18 Expression in Human M2 Macrophages.

Authors:  Susanne Mommert; Judith Tabea Schaper; Katrin Schaper-Gerhardt; Ralf Gutzmer; Thomas Werfel
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

Review 8.  Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics.

Authors:  Samantha Alvarez-Herrera; Raúl Escamilla; Oscar Medina-Contreras; Ricardo Saracco; Yvonne Flores; Gabriela Hurtado-Alvarado; José Luis Maldonado-García; Enrique Becerril-Villanueva; Gilberto Pérez-Sánchez; Lenin Pavón
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-21       Impact factor: 5.555

Review 9.  The Function of the Histamine H4 Receptor in Inflammatory and Inflammation-Associated Diseases of the Gut.

Authors:  Bastian Schirmer; Detlef Neumann
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

Review 10.  Histamine in cancer immunology and immunotherapy. Current status and new perspectives.

Authors:  María de la Paz Sarasola; Mónica A Táquez Delgado; Melisa B Nicoud; Vanina A Medina
Journal:  Pharmacol Res Perspect       Date:  2021-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.